Next report date
—
Report period
—
EPS estimate
—
Revenue estimate
—
−5.82 USD
−196.29 M USD
22.77 M USD
10.76 M
About Celularity Inc.
Sector
CEO
Robert Joseph Hariri Gordon
Website
Headquarters
Florham Park
Founded
2016
FIGI
BBG00P2RTT34
Celularity, Inc. is a clinical stage biotechnology company, which engages in the development of off-the-shelf placental-derived allogeneic cell therapies for the treatment of cancer and immune and infectious diseases. It operates through the following segments: Cell Therapy, BioBanking, Degenerative Disease, and Other. The Cell Therapy segment consists of the therapies the company is researching and developing. The BioBanking segment focuses on stem cells from umbilical cords and placentas and provides storage of such cells on behalf of individuals for future use. The Degenerative Disease segment offers products used in surgical and wound care markets. The company was founded by Robert Joseph Hariri Gordon in 2016 and is headquartered in Florham Park, NJ.
Displays a symbol's price movements over previous years to identify recurring trends.
Frequently Asked Questions
The current price of CELU is 2.76 USD — it has decreased by −3.06% in the past 24 hours. Watch Celularity Inc. stock price performance more closely on the chart.
Depending on the exchange, the stock ticker may vary. For instance, on NASDAQ exchange Celularity Inc. stocks are traded under the ticker CELU.
CELU stock has fallen by −18.57% compared to the previous week, the month change is a 38.35% rise, over the last year Celularity Inc. has showed a 32.06% increase.
CELU reached its all-time high on Jul 20, 2021 with the price of 134.00 USD, and its all-time low was 1.30 USD and was reached on Oct 31, 2024. View more price dynamics on CELU chart.
See other stocks reaching their highest and lowest prices.
See other stocks reaching their highest and lowest prices.
CELU stock is 14.34% volatile and has beta coefficient of 6.43. Track Celularity Inc. stock price on the chart and check out the list of the most volatile stocks — is Celularity Inc. there?
Today Celularity Inc. has the market capitalization of 62.72 M, it has increased by 15.96% over the last week.
Yes, you can track Celularity Inc. financials in yearly and quarterly reports right on TradingView.
Celularity Inc. is going to release the next earnings report on Nov 25, 2024. Keep track of upcoming events with our Earnings Calendar.
CELU net income for the last quarter is −6.49 M USD, while the quarter before that showed −22.01 M USD of net income which accounts for 70.53% change. Track more Celularity Inc. financial stats to get the full picture.
No, CELU doesn't pay any dividends to its shareholders. But don't worry, we've prepared a list of high-dividend stocks for you.
As of Nov 23, 2024, the company has 120.00 employees. See our rating of the largest employees — is Celularity Inc. on this list?
EBITDA measures a company's operating performance, its growth signifies an improvement in the efficiency of a company. Celularity Inc. EBITDA is −35.91 M USD, and current EBITDA margin is −294.91%. See more stats in Celularity Inc. financial statements.
Like other stocks, CELU shares are traded on stock exchanges, e.g. Nasdaq, Nyse, Euronext, and the easiest way to buy them is through an online stock broker. To do this, you need to open an account and follow a broker's procedures, then start trading. You can trade Celularity Inc. stock right from TradingView charts — choose your broker and connect to your account.
Investing in stocks requires a comprehensive research: you should carefully study all the available data, e.g. company's financials, related news, and its technical analysis. So Celularity Inc. technincal analysis shows the neutral today, and its 1 week rating is sell. Since market conditions are prone to changes, it's worth looking a bit further into the future — according to the 1 month rating Celularity Inc. stock shows the sell signal. See more of Celularity Inc. technicals for a more comprehensive analysis.
If you're still not sure, try looking for inspiration in our curated watchlists.
If you're still not sure, try looking for inspiration in our curated watchlists.